Literature DB >> 32120337

The pyrin inflammasome in host-microbe interactions.

Nicole A Loeven1, Natasha P Medici2, James B Bliska3.   

Abstract

Pyrin is an inflammasome sensor in phagocytes that is activated in response to bacterial toxins and effectors that modify RhoA. Pathogen effector-triggered pyrin activation is analogous to an indirect guard mechanism in plants. Pyrin activation appears to be triggered when RhoA GTPases in a host cell are prevented from binding downstream signaling proteins (transducers). RhoA transducers that control this response include PRK kinases, which negatively regulate pyrin by phosphorylation and binding of 14-3-3 proteins. Microtubules regulate pyrin at different levels and may serve as a platform for inflammasome nucleation. Pyrin increases inflammation in the lung, gut or systemically during infection or intoxication in mouse models and protects against systemic infection by decreasing bacterial loads. Pathogenic Yersinia spp. overcome this protective response using effectors that inhibit the pyrin inflammasome. Gain of function mutations in MEFV, the gene encoding pyrin, cause the autoinflammatory disease Familial Mediterranean Fever. Yersinia pestis may have selected for gain of function MEFV mutations in the human population.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32120337      PMCID: PMC7247927          DOI: 10.1016/j.mib.2020.01.005

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  59 in total

1.  Non-canonical inflammasome activation targets caspase-11.

Authors:  Nobuhiko Kayagaki; Søren Warming; Mohamed Lamkanfi; Lieselotte Vande Walle; Salina Louie; Jennifer Dong; Kim Newton; Yan Qu; Jinfeng Liu; Sherry Heldens; Juan Zhang; Wyne P Lee; Merone Roose-Girma; Vishva M Dixit
Journal:  Nature       Date:  2011-10-16       Impact factor: 49.962

Review 2.  Host inflammasome defense mechanisms and bacterial pathogen evasion strategies.

Authors:  Susan M Brewer; Sky W Brubaker; Denise M Monack
Journal:  Curr Opin Immunol       Date:  2019-06-04       Impact factor: 7.486

Review 3.  Evasion and interference: intracellular pathogens modulate caspase-dependent inflammatory responses.

Authors:  Mary K Stewart; Brad T Cookson
Journal:  Nat Rev Microbiol       Date:  2016-05-13       Impact factor: 60.633

4.  The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence.

Authors:  Melissa W McCoy; Meghan L Marré; Cammie F Lesser; Joan Mecsas
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

5.  Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.

Authors:  Jeffrey Ng; Simon A Hirota; Olaf Gross; Yan Li; Annegret Ulke-Lemee; Mireille S Potentier; L Patrick Schenck; Akosua Vilaysane; Mark E Seamone; Hanping Feng; Glen D Armstrong; Jurg Tschopp; Justin A Macdonald; Daniel A Muruve; Paul L Beck
Journal:  Gastroenterology       Date:  2010-04-13       Impact factor: 22.682

6.  Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence.

Authors:  Joseph B McPhee; Patricio Mena; James B Bliska
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

Review 7.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

8.  A Burkholderia Type VI Effector Deamidates Rho GTPases to Activate the Pyrin Inflammasome and Trigger Inflammation.

Authors:  Daniel F Aubert; Hao Xu; Jieling Yang; Xuyan Shi; Wenqing Gao; Lin Li; Fabiana Bisaro; She Chen; Miguel A Valvano; Feng Shao
Journal:  Cell Host Microbe       Date:  2016-04-28       Impact factor: 21.023

9.  Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation.

Authors:  Seth L Masters; Vasiliki Lagou; Isabelle Jéru; Paul J Baker; Lien Van Eyck; David A Parry; Dylan Lawless; Dominic De Nardo; Josselyn E Garcia-Perez; Laura F Dagley; Caroline L Holley; James Dooley; Fiona Moghaddas; Emanuela Pasciuto; Pierre-Yves Jeandel; Raf Sciot; Dena Lyras; Andrew I Webb; Sandra E Nicholson; Lien De Somer; Erika van Nieuwenhove; Julia Ruuth-Praz; Bruno Copin; Emmanuelle Cochet; Myrna Medlej-Hashim; Andre Megarbane; Kate Schroder; Sinisa Savic; An Goris; Serge Amselem; Carine Wouters; Adrian Liston
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

Review 10.  Alternative inflammasome activation enables IL-1β release from living cells.

Authors:  Moritz M Gaidt; Veit Hornung
Journal:  Curr Opin Immunol       Date:  2016-11-11       Impact factor: 7.486

View more
  14 in total

Review 1.  The pyrin inflammasome and the Yersinia effector interaction.

Authors:  Haleema S Malik; James B Bliska
Journal:  Immunol Rev       Date:  2020-07-28       Impact factor: 12.988

Review 2.  Pyroptosis and pyroptosis-inducing cancer drugs.

Authors:  Fan Yang; Sahana N Bettadapura; Mark S Smeltzer; Hua Zhu; Shanzhi Wang
Journal:  Acta Pharmacol Sin       Date:  2022-03-14       Impact factor: 7.169

Review 3.  Reprogramming of Cell Death Pathways by Bacterial Effectors as a Widespread Virulence Strategy.

Authors:  Joseph J Wanford; Abderrahman Hachani; Charlotte Odendall
Journal:  Infect Immun       Date:  2022-04-25       Impact factor: 3.609

Review 4.  Inflammasome activation and evasion by bacterial pathogens.

Authors:  Atri Ta; Sivapriya Kailasan Vanaja
Journal:  Curr Opin Immunol       Date:  2020-12-15       Impact factor: 7.486

Review 5.  Therapeutic implications of inflammasome in inflammatory bowel disease.

Authors:  Vishal Khatri; Ramaswamy Kalyanasundaram
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

Review 6.  Inflammasome and Mitophagy Connection in Health and Disease.

Authors:  Jae-Min Yuk; Prashanta Silwal; Eun-Kyeong Jo
Journal:  Int J Mol Sci       Date:  2020-07-01       Impact factor: 5.923

Review 7.  Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes.

Authors:  Meenakshi Sharma; Eva de Alba
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

Review 8.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

9.  Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection.

Authors:  Lamyaa Shaban; Giang T Nguyen; Benjamin D Mecsas-Faxon; Kenneth D Swanson; Shumin Tan; Joan Mecsas
Journal:  PLoS Pathog       Date:  2020-05-11       Impact factor: 6.823

Review 10.  Robust microbe immune recognition in the intestinal mucosa.

Authors:  Olivier P Schären; Siegfried Hapfelmeier
Journal:  Genes Immun       Date:  2021-05-06       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.